Loading...

IL-33 in Tumor Immunity: Nothing to Sneeze At

Although immunotherapy has been at the forefront of cancer therapy for the last several years, better clinical responses are still desired. Interleukin-33 is perhaps one of the most overlooked antitumor cytokines. Its ability to promote type 1 immune responses, winch control tumor growth in preclini...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Crit Rev Immunol
Main Authors: Dominguez, Donye, Zhang, Yi, Zhang, Bin
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087446/
https://ncbi.nlm.nih.gov/pubmed/31002600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/CritRevImmunol.2018026335
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!